Back
Brady Vs. Neurogene Industry Stock Comparison
Buy
62
BRC
Brady
Last Price:
74.18
Seasonality Move:
6.16%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Buy
62
Brady (BRC)
is a Buy
Is Brady a Buy, Sell or Hold?
- The current Brady [BRC] share price is $74.21. The Score for BRC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- BRC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BRC Stock Price Chart
BRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 48.91 | Sell |
Chaikin Money Flow: | -10020 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.35 - 75.97) | Buy |
Bollinger Bands (100): | (68.8 - 75.28) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 35.74 | Sell |
Chaikin Money Flow: | -452975 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.4 - 61.5) | Sell |
Bollinger Bands (100): | (34.32 - 50.52) | Sell |
BRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 75.89 | Sell |
20-day SMA: | 73.86 | Buy |
50-day SMA: | 74.28 | Sell |
200-day SMA: | 66.61 | Buy |
8-day EMA: | 75.05 | Sell |
20-day EMA: | 74.53 | Sell |
50-day EMA: | 73.78 | Buy |
200-day EMA: | 67.71 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.3 | Sell |
20-day SMA: | 51.47 | Sell |
50-day SMA: | 46.76 | Sell |
200-day SMA: | 38.99 | Sell |
8-day EMA: | 47.13 | Sell |
20-day EMA: | 50.2 | Sell |
50-day EMA: | 47.47 | Sell |
200-day EMA: | 38.44 | Sell |
Brady Earnings Growth & BRC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.46 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Brady Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |